{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:48:29Z","timestamp":1772801309708,"version":"3.50.1"},"reference-count":127,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Rheumatology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1080\/03009740510026599","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T08:19:25Z","timestamp":1126081165000},"page":"178-190","source":"Crossref","is-referenced-by-count":41,"title":["Therapy of ankylosing spondylitis. Part II: Biological therapies in the spondyloarthritides"],"prefix":"10.1080","volume":"34","author":[{"given":"J.","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,12]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/38.9.831","volume":"38","author":"Brandt J","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"CIT0003","first-page":"359","volume":"44","author":"Gran JT","year":"1985","journal-title":"Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Ann Rheum Dis"},{"key":"CIT0004","first-page":"2622","volume":"26","author":"Saraux A","year":"1999","journal-title":"Societe de Rhumatologie de l'Ouest. J Rheumatol"},{"key":"CIT0005","first-page":"613","volume":"27","author":"Zink A","year":"2000","journal-title":"German Collaborative Arthritis Centers. J Rheumatol"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1529-0131(199908)12:4<247::AID-ART3>3.0.CO;2-H","volume":"12","author":"Ward MM","year":"1999","journal-title":"Arthritis Care Res"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/ard.60.3.199","volume":"60","author":"Zink A","year":"2001","journal-title":"Structure, aims, and patients. Ann Rheum Dis"},{"key":"CIT0008","first-page":"353","volume":"60","author":"Boonen A","year":"2001","journal-title":"Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis"},{"key":"CIT0009","first-page":"693","volume":"61","author":"Chorus AM","year":"2002","journal-title":"Employment perspectives of patients with ankylosing spon-dylitis. Ann Rheum Dis"},{"key":"CIT0010","first-page":"429","volume":"61","author":"Boonen A","year":"2002","journal-title":"Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.8.741"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/1529-0131(200201)46:1<223::AID-ART498>3.0.CO;2-#","volume":"46","author":"Ward M","year":"2002","journal-title":"Arthritis Rheum"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2003.017327","volume":"63","author":"Listing J","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"CIT0015","first-page":"117","volume":"21","author":"Amor B","year":"1995","journal-title":"Management of refractory ankylosing spondylitis and related spondyloarthro-pathies. Rheum Dis Clin North Am"},{"key":"CIT0016","first-page":"1420","volume":"29","author":"Ward MM","year":"2002","journal-title":"J Rheumatol"},{"key":"CIT0017","first-page":"430","volume":"45","author":"Van Tubergen A","year":"2001","journal-title":"Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/ar592","volume":"4","author":"Braun J","year":"2002","journal-title":"Arthritis Res"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1517\/13543784.12.7.1097","volume":"12","author":"Braun J","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/art.20159","volume":"50","author":"Maini R","year":"2004","journal-title":"Arthritis Rheum"},{"key":"CIT0021","first-page":"37","volume":"112","author":"Wagner CL","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"CIT0022","first-page":"601","volume":"348","author":"Baert F","year":"2003","journal-title":"Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00002281-199607000-00003","volume":"8","author":"Braun J","year":"1996","journal-title":"CUff Opin Rheumatol"},{"key":"CIT0024","first-page":"694","volume":"41","author":"Mcgonagle D","year":"1998","journal-title":"Characteristic magnetic resonance imaging enthe-seal changes of knee synovitis in spondylarthropathy. Arthritis Rheum"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780370709","volume":"37","author":"Braun J","year":"1994","journal-title":"Arthritis Rheum"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/art.10934","volume":"48","author":"Muche B","year":"2003","journal-title":"Arthritis Rheum"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.4.316"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380407"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.59.2.135","volume":"59","author":"Bollow M","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"Sands BE","year":"2004","journal-title":"N Engl J Med"},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00054725-199905000-00008","volume":"5","author":"Sandbom WJ","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"CIT0034","first-page":"2112","volume":"44","author":"Marzo-Ortega H","year":"2001","journal-title":"Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum"},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/ard.61.3.207","volume":"61","author":"Kruithof E","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"CIT0037","first-page":"1605","volume":"28","author":"Stone M","year":"2001","journal-title":"J Rheumatol"},{"key":"CIT0038","first-page":"959","volume":"29","author":"Maksymowych WP","year":"2002","journal-title":"J Rheumatol"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/rheumatology\/41.11.1280","volume":"41","author":"Breban M","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/ard.2002.004879","volume":"62","author":"Collantes-Estevez E","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1002\/art.11104"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard.2003.014258","volume":"62","author":"Temekonidis TI","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","volume":"43","author":"Brandt J","year":"2000","journal-title":"Arthritis Rheum"},{"key":"CIT0044","first-page":"2286","volume":"21","author":"Garrett S","year":"1994","journal-title":"J Rheumatol"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08215-6"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1002\/art.20852"},{"issue":"1","key":"CIT0049","first-page":"400","volume":"63","author":"Braun J","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/ard.2004.025130","volume":"64","author":"Braun J","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"CIT0052","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/rheumatology\/keh584","volume":"44","author":"Braun J","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1521-6942(02)90250-0","volume":"16","author":"Braun J","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1002\/art.10883"},{"key":"CIT0056","first-page":"127","volume":"64","author":"Creemers MC","year":"2005","journal-title":"Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.015933"},{"key":"CIT0060","first-page":"426","volume":"63","author":"Van Vollenhoven RF","year":"2004","journal-title":"Klareskog L. Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect. Ann Rheum Dis"},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","volume":"126","author":"Rutgeerts P","year":"2004","journal-title":"Gastroenterology"},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.10812","volume":"48","author":"D'Agostino MA","year":"2003","journal-title":"Arthritis Rheum"},{"key":"CIT0063","first-page":"1349","volume":"346","author":"Gorman JD","year":"2002","journal-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1002\/art.11017"},{"key":"CIT0065","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/art.11325","volume":"48","author":"Davis JC Jr, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, et al.","year":"2003","journal-title":"Arthritis Rheum"},{"key":"CIT0066","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/art.20241","volume":"51","author":"Davis J Jr, Webb A, Lund S, Sack K.","year":"2004","journal-title":"Arthritis Rheum"},{"key":"CIT0067","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/rheumatology\/keh475","volume":"44","author":"Brandt J","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"CIT0069","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/art.20977","volume":"52","author":"Baraliakos X","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"CIT0070","first-page":"399","volume":"64","author":"Haibel H","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"CIT0071","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00063030-200317030-00005","volume":"17","author":"Braun J","year":"2003","journal-title":"BioDrugs"},{"key":"CIT0072","first-page":"1138","volume":"42","author":"Pipitone N","year":"2003","journal-title":"Current concepts and new developments in the treatment of psoriatic arthritis. Rheumatology (Oxford)"},{"key":"CIT0073","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/ard.61.4.298","volume":"61","author":"Mease PJ","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"CIT0074","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/art.20181","volume":"50","author":"Canete JD","year":"2004","journal-title":"Arthritis Rheum"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04954-0"},{"key":"CIT0076","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","volume":"349","author":"Leonardi CL","year":"2003","journal-title":"N Engl J Med"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.018085"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02530-7"},{"key":"CIT0079","first-page":"506","volume":"47","author":"Antoni C","year":"2002","journal-title":"Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflamma-tion. Arthritis Rheum"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1002\/art.11201"},{"key":"CIT0081","first-page":"2013","volume":"39","author":"Clegg DO","year":"1996","journal-title":"A Department of Veterans Affairs Cooperative Study. Arthritis Rheum"},{"key":"CIT0082","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/art.20967","volume":"52","author":"Antoni CE","year":"2005","journal-title":"Arthritis Rheum"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00753.x"},{"key":"CIT0084","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1468-3083.2002.00391.x","volume":"16","author":"Wollina U","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"CIT0085","first-page":"5130","volume":"20","author":"Meador R","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"CIT0086","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/03009740310000157","volume":"32","author":"Oili KS","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"CIT0087","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"Dougados M","year":"1991","journal-title":"Arthritis Rheum"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.6.428"},{"key":"CIT0089","first-page":"118","volume":"29","author":"Brandt J","year":"2002","journal-title":"Successful short term treatment of severe undifferentiated spondylo-arthropathy with the anti-tumor necrosis factor-alpha mono-clonal antibody infliximab. J Rheumatol"},{"key":"CIT0090","first-page":"531","volume":"31","author":"Brandt J","year":"2004","journal-title":"J Rheumatol"},{"key":"CIT0091","first-page":"750","volume":"28","author":"Karppinen J","year":"2003","journal-title":"Spine"},{"key":"CIT0092","first-page":"1120","volume":"63","author":"Genevay S","year":"2004","journal-title":"Gabay C. Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study. Ann Rheum Dis"},{"key":"CIT0093","first-page":"5152","volume":"20","author":"Antoni C","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"CIT0094","first-page":"3013","volume":"48","author":"Ellerin T","year":"2003","journal-title":"Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum"},{"key":"CIT0095","first-page":"1098","volume":"345","author":"Keane J","year":"2001","journal-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med"},{"key":"CIT0096","first-page":"2122","volume":"48","author":"Gomez-Reino JJ","year":"2003","journal-title":"MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.047"},{"key":"CIT0099","first-page":"3151","volume":"46","author":"Brown SL","year":"2002","journal-title":"Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W"},{"key":"CIT0101","first-page":"807","volume":"138","author":"Kwon HJ","year":"2003","journal-title":"Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med"},{"key":"CIT0102","first-page":"3133","volume":"107","author":"Chung ES","year":"2003","journal-title":"Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart fail-ure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(02)00470-9"},{"key":"CIT0104","first-page":"2383","volume":"43","author":"Charles PJ","year":"2000","journal-title":"Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum"},{"key":"CIT0105","first-page":"1015","volume":"48","author":"De Rycke L","year":"2003","journal-title":"Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. Arthritis Rheum"},{"key":"CIT0106","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/ard.61.4.375","volume":"61","author":"Olivieri I","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"CIT0107","first-page":"1965","volume":"46","author":"Wagner AD","year":"2002","journal-title":"Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syn-drome. Arthritis Rheum"},{"key":"CIT0108","first-page":"1959","volume":"50","author":"Bergstrom L","year":"2004","journal-title":"Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum"},{"key":"CIT0109","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/107110070402500510","volume":"25","author":"Bibbo C","year":"2004","journal-title":"Foot Ankle Int"},{"key":"CIT0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002030-200401230-00015","volume":"18","author":"Wallis RS","year":"2004","journal-title":"Aids"},{"key":"CIT0111","first-page":"107","volume":"31","author":"Oniankitan","year":"2004","journal-title":"Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C. J Rheumatol"},{"key":"CIT0112","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/ard.2004.023473","volume":"64","author":"Feltelius N","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"CIT0113","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","volume":"50","author":"Wolfe F","year":"2004","journal-title":"Arthritis Rheum"},{"key":"CIT0114","first-page":"657","volume":"64","author":"Franklin JP","year":"2005","journal-title":"Risk of lymphoma in patients with RA treated with anti-TNFalpha agents. Ann Rheum Dis"},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.030528"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.09.039"},{"key":"CIT0119","first-page":"447","volume":"51","author":"Gonzalez-Juanatey C","year":"2004","journal-title":"Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. Arthritis Rheum"},{"key":"CIT0120","first-page":"R264","volume":"6","author":"Bobbio-Pallavicini F","year":"2004","journal-title":"Autoantibody profile in rheuma-toid arthritis during long-term infliximab treatment. Arthritis Res Ther"},{"key":"CIT0121","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keh205","volume":"43","author":"Braun J","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"CIT0122","first-page":"283","volume":"33","author":"Elkayam","year":"2004","journal-title":"The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum"},{"key":"CIT0123","first-page":"1356","volume":"31","author":"Mease PJ","year":"2004","journal-title":"J Rheumatol"},{"key":"CIT0124","first-page":"2287","volume":"30","author":"Jarrett SJ","year":"2003","journal-title":"J Rheumatol"},{"key":"CIT0125","first-page":"587","volume":"62","author":"Unger L","year":"2003","journal-title":"Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis"},{"key":"CIT0126","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07457.x"},{"key":"CIT0128","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/art.10139","volume":"46","author":"Maksymowych WP","year":"2002","journal-title":"Arthritis Rheum"},{"key":"CIT0129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.10396","volume":"47","author":"Huang F","year":"2002","journal-title":"Arthritis Rheum"},{"key":"CIT0130","first-page":"1876","volume":"44","author":"Anderson JJ","year":"2001","journal-title":"Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylos-ing spondylitis. Arthritis Rheum"},{"key":"CIT0131","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/art.20414","volume":"51","author":"Stone MA","year":"2004","journal-title":"Arthritis Rheum"},{"key":"CIT0132","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/ard.62.3.215","volume":"62","author":"Van Tubergen A","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"CIT0133","first-page":"1438","volume":"63","author":"Brandt J","year":"2004","journal-title":"Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis. Ann Rheum Dis"},{"key":"CIT0134","first-page":"380","volume":"46","author":"Brandt J","year":"2002","journal-title":"Improvement criteria for treatment with biologics of patients with ankylosing spondylitis - a proposal based on data from a recent randomized trial with the anti-TNFa agent infliximab. Arthritis Rheum"},{"key":"CIT0135","first-page":"1098","volume":"31","author":"Hansen KE","year":"2004","journal-title":"J Rheumatol"},{"key":"CIT0136","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/ard.2003.009589","volume":"62","author":"Van Vollenhoven R","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"CIT0137","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/rheumatology\/keh271","volume":"43","author":"Kobelt G","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"CIT0138","first-page":"530","volume":"63","author":"Landewe R","year":"2004","journal-title":"Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists. Ann Rheum Dis"},{"key":"CIT0139","first-page":"817","volume":"62","author":"Braun J","year":"2003","journal-title":"International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis"},{"key":"CIT0140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/ard.62.9.812","volume":"62","author":"Pham T","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"CIT0141","first-page":"1883","volume":"21","author":"Amor B","year":"1994","journal-title":"Predictive factors for the longterm outcome of spondylo-arthropathies. J Rheumatol"}],"container-title":["Scandinavian Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03009740510026599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T23:10:49Z","timestamp":1497654649000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03009740510026599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":127,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,7,12]]},"published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1080\/03009740510026599"],"URL":"https:\/\/doi.org\/10.1080\/03009740510026599","relation":{},"ISSN":["0300-9742","1502-7732"],"issn-type":[{"value":"0300-9742","type":"print"},{"value":"1502-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}